Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B

PURPOSE: There are remarkable advances in the treatment of chronic hepatitis B (CHB) in the last few years. Unfortunately, prolonged antiviral treatment is associated with increasing risk of drug resistance/viral breakthrough (VBT), which may lead to flare-up and rapid decompensation. We have design...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Alam, Shahinul, Azam, Golam, Mustafa, Golam, Ahmad, Nooruddin, Islam, Belalul, Podder, Provat Kumar, Khan, Mobin
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2008
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716900/
https://ncbi.nlm.nih.gov/pubmed/19669325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-008-9095-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki